Effects of Endocrine Metabolic Factors on Hemocyte Parameters, Tumor Markers, and Blood Electrolytes in Patients with Hyperglycemia

Table 6

Comparison of clinical data of patients in the and groups.

Items	()	()	or	value
Male/female	415/338	13/7	0.771	0.380
Average age (years)	54	46	-2.379	0.017
AST (U/L)	18.2	20.35	-0.887	0.375
ALT (U/L)	19.7	23.05	-0.615	0.538
Cre (μmol/L)	70.6	59.6	-1.324	0.185
UA (μmol/L)	347.4	383.4	-0.545	0.586
FBG (mmol/L)	6.0	7.425	-1.577	0.115
TC (mmol/L)	4.15	4.71	-2.281	0.023
F-CHOL	1.43	1.75	-3.270	0.001
TG (mmol/L)	1.60	2.335	-2.790	0.005
HDL-C (mmol/L)	1.02	0.95	-0.590	0.555
LDL-C (mmol/L)	2.54	3.005	-1.621	0.105
BMI (kg/m^2)	24.141	23.90	-0.919	0.358

Note: data are shown as mean (independent sample -test). NSE: neuron-specific enolase; AST: aspartate aminotransferase; ALT: alanine aminotransferase; Cre: creatinine; UA: uric acid; FBG: fasting blood glucose; TC: total cholesterol; F-CHOL: free cholesterol; TG: triglyceride; HLD-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; Ka: serum kalium; Na: serum sodium; Cl: serum chlorine; Ca: serum calcium; Mg: serum magnesium; P: serum phosphorus; Zn: serum zinc; BMI: body mass index.